Power3 Medical Products In Collaboration with StemTroniX, Inc., to Identify and Monitor Autologous Adult Stem Cells for Use In Stem Cell Therapy Using Protein Biomarkers

HOUSTON--(BUSINESS WIRE)--Power3 Medical Products, Inc. (OTCBB:PWRM), (www.power3medical.com), today announced that the company has executed a Letter of Intent with StemTroniX, Inc., a Texas based Stem Cell Therapy Company that specializes in research, exploration and consolidation of stem cell technologies for use in Autologous Adult Stem Cell Therapy’s and Transplantations.
MORE ON THIS TOPIC